Q3 2020 Sales Performance

Adjusted operating margin gsk Sales and Adjusted operating margins Q3 2020 Sales All figures £m Q3 2019 sales at '19 rates Pro Forma sales at '19 rates 2019 sales at '19 rates (PF) Pharma down -3% CER Vaccines down -9% CER 9,385 213 9,598 122 205 Consumer down -6% CER 153 Q3 2019 operating margin Pro Forma impact on margin Q3 2019 Pro Forma margin COGS down 8% CER SG&A down 10% CER R&D down 7% CER 29.7% 0.2% 29.5% 1.0% 1.5% +2.4% CER 0.2% Corporate down -96% CER 24 CER -5% 9,093 Royalties down 26% CER Q3 2020 margin at 19 FX 0.3% 31.9% FX -5% 447 Currency 1.1% AER -10% 8,646 Q3 2020 margin at 20 FX 30.8% 92 42

View entire presentation